They say this approach could lead to a reduction in the number of vaccines that need to be administered to each bird.
Vaccines that target multiple diseases are in high demand due to the many viruses that can circulate simultaneously in flocks. Protecting against the most dangerous diseases with one vaccine could reduce overall vaccination costs for poultry producers and decrease the number of times that birds need to be handled.
The researchers demonstrated that a gene editing system called CRISPR/cas9 can be used to insert a gene of the IBD virus into the currently used Marek’s disease vaccine virus. The added genetic material protects poultry against IBD in addition to the protection already offered by the Marek’s disease vaccine, meaning that bird owners would only need to use one vaccine instead of two.
Other vaccines generated by conventional methods can achieve a similar result, but by using the CRISPR/cas9 system the Pirbright researchers say they have been able to insert the IBD gene far more quickly, easily and accurately than the methods that have been used before. This will significantly reduce the time needed to generate new vaccines.
Professor Venugopal Nair, joint leader of the research at Pirbright said: "The method we have created with CRISPR/cas9 really increases the scope of how we edit the Marek’s disease vaccine to include other virus components. Now we have shown that the gene-edited vaccine protects against both Marek’s disease and IBD, we are looking at inserting more genes from other viruses."
The team intend to generate a vaccine that will be able to protect against multiple avian diseases and will next target two high consequence poultry viruses - avian influenza virus and the Newcastle disease virus. The flexibility of the new method also means that as the viruses evolve, the vaccine virus can be easily edited to include new genes which protect against emerging strains.
The Pirbright Institute says there has been huge commercial interest in using this technology to develop novel vaccines, so it intends to partner vaccine manufacturing companies to bring CRISPR/cas9 edited vaccines to market.
This scientific paper can be found in the Vaccine journal and was funded by the Biotechnology and Biological Sciences Research Council (BBSRC); grant numbers BB/P016472/1 BB/L014262/1.
Photo: Cells infected with the Marek's disease vaccine virus, HVT, (green) expressing the inserted infectious bursal disease virus gene, VP2 (red). Cell nuclei are shown in blue. © Dr Na Tang, The Pirbright Institute 2018.
The RCVS is holding a session at the London Vet Show on Saturday 23rd October from 8:30am-9:30am to provide guidance and advice concerning the work your nursing team does in practice.
As the RCVS says, the recent Panorama programme "It shouldn't happen at a vets'" was a stark reminder of the importance of ensuring that all practice staff are working within the appropriate legal framework.
The session will answer such questions as:
Because of the early start, the RCVS is providing breakfast from 8:15am, though I wouldn't get your hopes up for eggs benedict and freshly smoked Loch Fyne kippers.
The RCVS says the session will be relevant for all members of the practice team, but that if you can't make the session, they will be on hand to discuss VN legislation on stand M26.
Consultations are delivered online using video conferencing software, with the aim being to provide an immediate diagnosis and treatment plan. However, if a diagnosis cannot be made remotely, or the situation requires intensive medical or surgical intervention, Optivet offers non-contact clinical facilities in Hampshire, London and the Isle of Wight, or will recommend other, closer ophthalmology facilities if necessary.
Optivet says it has the medical and surgical expertise to deal with any ongoing issues and follow-up is provided remotely wherever possible.
Rob Lowe, RCVS Specialist in Veterinary Ophthalmology and founder of Optivet, said: “We have come up with an innovative, non-contact ophthalmology solution for both the present and the future. Optivet’s response time and immediate availability of an ophthalmology specialist is unmatched in the UK.
"Once you become a client, you become part of the Optivet family. Our amazing team will work with you throughout the patient journey to provide the highest level of care.”
For more information, visit: remote.optivet.com
Mark Bordo, CEO and CoFounder, Vetster.com, said: “Our new mobile app is one more way we can provide veterinary professionals with a flexible platform to connect with pet parents in between appointments, traveling between clients, or from the comfort of home. With just a few taps on their mobile phone, veterinarians connect with pet parents with great video quality, and easy-to-use scheduling and follow-up features.”
So now, at long last, vets can diagnose disease in animals on an even smaller screen than ever before.
What a breakthrough.
The mobile app also means you can diagnose whilst on the move.
So, no need to waste any more time reading a book on the 14:25 from Paddington to Bath Spa, instead you could be consulting pet owners (or 'pet parents' ... ugh) and examining their animal on your two inch mobile phone screen from the comfort of your train seat.
Client confidentiality could be a problem on the 14:25, but if you wear headphones and whisper into the phone, you should be alright.
Tunnels might also cause a bit of a problem, but hey, the pet owner can always call you back when you're out the other side.
To register to practice on Vetster, visit vetster.com.
Once registered and approved, you can then download and use the app.
The factsheets, which cover canine chronic bronchitis, feline asthma and equine asthma, are designed to help explain complex conditions more effectively, encourage earlier diagnosis, and improve treatment compliance.
The downloadable factsheets can be printed, emailed to clients, or displayed in waiting areas and on waiting room screens.
Jon Slattery MRCVS, Director of BreathEazy, said: “We often see a seasonal spike in respiratory cases at this time of year, particularly in animals with underlying conditions.
"Having owners on board and confident in managing their pet’s condition is a key part of treatment success.
"These factsheets offer a time-saving way for vets and nurses to educate clients, reinforce advice given in consults, and help owners understand how to support their pets at home.”
https://mailchi.mp/breatheazy/resourcedownload
www.breatheazy.co.uk
The RCVS has removed 563 veterinary surgeons from the Register from 1 June for non-payment of retention fees.
A list of those who remained off the Register as of 31 July 2012 is available here: www.rcvs.org.uk/removals2012.
The College says it is publicising the list to help make sure that those who have been removed, and their employers, are aware; it includes only those not restored prior to 31 July.
Christine Fraser, RCVS Head of Registration said: “If you know anyone who appears on this list and who is still working in the UK, you may wish to advise them they need to contact the RCVS as a matter of urgency to restore their name to the Register."
The RCVS is asking veterinary surgeons who have not yet confirmed their registration details, which is now part of the annual renewal process, to please make sure this is done by 30 September. A form was enclosed with the annual fee-reminder, or this can be done online at www.rcvs.org.uk/registration.
Information about how veterinary surgeons removed after non-payment can restore themselves to the Register is available at www.rcvs.org.uk/registration, or by contacting the RCVS Registration Department (membership@rcvs.org.uk or 0207 202 0707).
Petplan has teamed up with Battersea Dogs & Cats Home to launch Summer Safety, a pet owner education campaign based on insurance claims received by the company.
The company reports that last year, 83% of all heat stroke claims occurred in the summer months (June-August), with 48% of them in July alone. Almost half of all heat stroke claims last year came in at an average of £315, with the highest claim reaching nearly £600.
80% of grass seed claims happened between June and August last year, 41% of which happened in July. The highest grass seed claim paid out by Petplan last year was just over £3,600, with the top ten highest grass seed claims totalling over £18,500.
Petplan says it also sees a significant spike in claims for injuries resulting from other foreign bodies in ears and paws in the summer months. Last year, 77% of claims arising from foreign bodies in ears and 55% for foreign bodies in paws occurred between June and August.
In order to alleviate the risk to pets and highlight the danger, Petplan and Battersea Dogs & Cats Home have created a guide to help pet owners determine how at-risk to heat their pet is. The guide is available to download at petplan.co.uk/summersafety and Battersea.org.uk/funinthesun.
Petplan's vet Brian Faulkner MRCVS said: "Using the simple four step process, the guide encourages pet owners to answer a series of questions that reveals their pet's SPF score, whilst including useful tips to help keep their pet out of harm's way during the hotter months. The scale calculates a pet's risk to retaining heat based on four factors, those being; coat colour, coat type, length of the animal's nose and its age, to determine either a low, medium or high risk susceptibility."
Located in the South East of England, the centre is part of the new School of Veterinary Medicine at the University of Surrey, and one of the UK's largest veterinary pathology centres, offering high-containment post-mortem examination facilities and histopathology.
The centre is staffed by a team of board-certified veterinary pathologists, veterinary investigation officers and technicians, with expertise in farm-animal, equine, exotic and small-animal pathology.
The new building centres on a large containment level 2 post-mortem examination room with high ceilings, natural lighting, post-mortem examination tables, biological safety cabinets and integrated cold rooms, all served by a powerful winch system which means that post-mortem examinations can be performed on a wide range of species. A viewing gallery overlooks the suite and post-mortem examinations can be recorded and streamed for training purposes.
Professor Roberto La Ragione, Director of the Veterinary Pathology Centre, said: "Veterinary pathology is a growing discipline and its importance has been highlighted in recent disease outbreaks and the important role veterinary pathologists make in drug development. Helping the farming community to be more effective, sustainable and innovative, the Centre will work with partners, businesses and researchers to address some of the unique challenges faced by the veterinary and scientific community.
"It is the close relationships with our external clinical and scientific partners that enables us to be innovative in our approach to education and training here at the Surrey. An example of the latter is the use of digital pathology in teaching, research and diagnostics, which was the subject of discussion at the recent launch of the Veterinary Health Innovation Engine (vHive).
"Together with our partners such as the National Physical Laboratory and the 5G Innovation centre, the Centre is at the forefront of the digitalisation of pathology and innovative big data management.
"The Centre offers the opportunity to inspire the next generation of veterinary pathologists and complements the centres of excellence that already exist in other vet schools and research institutes."
The events will cover a range of subjects designed to boost morale, positively influence wellbeing and reduce the impact of seasonal affective disorder (SAD). They will also demonstrate how to support employees and colleagues to ensure work is sustainable, productive and enjoyable and guide veterinary professionals through mechanisms to make working life a more positive experience, despite the current climate.
The series will feature 30-minute presentations by wellbeing professionals such as sports psychiatrist, Dr Claire Gillvray (pictured right), human factors specialist, Dan Tipney, and occupational psychologist, Prof Elinor O’Connor.
The full programme is:
Liz Barton, co-founder of WellVet, said: “WellVet exists to provide practical tools and a supportive network to help positively influence and improve wellbeing and boost morale. This programme of events is designed to answer specific challenges we’re experiencing – now more than ever in veterinary teams, and to bring us together for a bit of festive cheer."
Emma McAnally, territory manager at Boehringer Ingelheim. said: “During these challenging times, work and life in general can often seem overwhelming. We are delighted to support the WellVet Winter Wellbeing series to help improve wellbeing both in the work and home environments.”
For further information on the WellVet Winter Wellbeing series and for details on how to join visit www.wellvet.co.uk.
One £20,000 grant will be awarded each year for five years, starting in 2019 (making a £100,000 total by 2023) to fund research that focuses on mental health and wellbeing within the veterinary professions, including areas such as prevention, diagnosis, intervention and treatment.
Applications are welcome from individuals at all stages of their research careers, including those who have not previously been published, with research proposals relating to any aspect of mental health or wellbeing in the veterinary professions. Researchers must be affiliated with a university, and ethical approval must be in place.
RCVS CEO, Lizzie Lockett, said: "Sarah Brown was a talented veterinary surgeon who was passionate about her profession. She was respected and loved by so many people and worked hard to support others. So it is fitting that, with the blessing of Sarah’s family, we are able to launch this grant in her memory. It’s only by improving the veterinary mental health evidence base that we will be able to hone the interventions and support that is available to members of the veterinary team."
Applicants should send their research proposal, along with a CV and short biography for all lead researchers, to Lisa Quigley, Mind Matters Initiative Manager, by 5pm on Friday 31 May 2019.
Each proposal should be a maximum of 3,000 words and should include aims, methods, ethical considerations, proposed timelines, and a bibliography. Any academic literature referred to within the proposal should be accurately referenced. The winner of the grant will be decided in June 2019, with the winner then receiving their award at Royal College Day in London on Friday 12 July 2019.
The recipient of the Sarah Brown Mental Health Research Grant for 2019 will be invited to present their research findings at the biennial Mind Matters Initiative Research Symposium in 2021.
Applications are particularly welcomed from those at an early stage in their research career. Guidance on how to prepare a research proposal is available at: https://esrc.ukri.org/funding/guidance-for-applicants/how-to-write-a-good-research-grant-proposal
Boehringer Ingelheim Vetmedica has launched Benefortin (benazepril hydrochloride), an ACE inhibitor licensed for the treatment of congestive heart failure (CHF) in dogs. It is also licensed for the treatment of chronic renal insufficiency (CRI) in cats.
Benefortin uses novel micro-cap technology to mask the taste of the bitter molecule. According to Boehringer, this ensures that Benefortin tastes good1, even if it is bitten, crunched or chewed. The company says taste tests demonstrated 100% palatability in dogs and 92% palatability in cats in home settings1.
Benefortin is available in 5mg and 20mg tablets for dogs and 2.5mg tablets for cats and dogs.
Jemima Scott, Boehringer Ingelheim brand manager said: "The addition of Benefortin to our cardiology portfolio now enables us to provide veterinary practices with two of the cornerstones of canine CHF treatment, and the palatability of Benefortin makes it an excellent choice for vets needing to prescribe an ACE inhibitor."
To support the launch of Benefortin, Boehringer is offering veterinary practices the opportunity to win one of three Bosch microwave ovens in a prize draw by answering three multiple choice questions on the ACE inhibitor.
For further information on Benefortin, contact your local Boehringer Ingelheim Vetmedica territory manager or telephone 01344 746959.
Norbrook Laboratories has announced the launch of Cefimam LC intramammary ointment for the management of mastitis.
Norbrook's large animal vet adviser Stephanie Small MRCVS said: "With such a broad range of treatments to choose from, vets are able to choose the product which best fits the situation. Cefimam® LC brings a powerful antimicrobial to the mix with high penetration for more difficult mastitis cases. Only three applications are required, which means fast resolution and rapid return of affected animals to production.
"This company firmly supports the large animal sector: as well as our commitment to making effective treatments affordable, we are investing in the future of the industry. We have worked closely with leading dairy vets to produce best practice materials for farming clients, and there are more educational tools in development."
Amongst these is a new guide called The Best Practice Guide for On-Farm Mastitis Control which you can now get from your Norbrook Territory Manager.
Cefimam LC is now available at all veterinary wholesalers in packs of 24 x 8g intramammary tubes.
For further information on Cefimam® LC, contact Senior Product Manager Chris Geddes MRCVS on 01536 741147
The charity is asking everyone to donate £5 and nominate 5 friends to get involved in the activities.
The activities are:
For more information, visit: https://www.vetlife.org.uk
Vetlife Helpline is available 24 hours a day, 365 days a year on: 0303 040 2551 or via anonymous email at https://helpline.vetlife.org.uk
This year’s Protect and Prevent campaign urged rabbit owners to get their rabbits vaccinated, following the continued outbreak of rabbit viral haemorrhagic disease (RVHD2). Veterinary practices were also urged to make sure they were stocking the necessary vaccines to protect rabbits against RVHD2, RVHD and myxomatosis.
The company says that over 5000 campaign packs were downloaded from the Rabbit Awareness Week website and sales of RVHD2 vaccines in the veterinary sector in June 2019 were 55% up on June 2018.
Peter Lancaster, Marketing Manager at Burgess Pet Care said: "We would like to say a huge thank you to the RAW partners, veterinary practices, rescue centres, pet shop retailers and, of course, rabbit owners, for their continued support in helping us to improve the health and wellbeing of rabbits."
Dr Richard Saunders BVSc DZooMed MRCVS, veterinary advisor to RWAF said: "We heard lots of heart-breaking stories from owners and vets alike about rabbits, sometimes whole groups of rabbits, which had not been vaccinated. None of those people realised just how widespread the RVHD2 is, and how easy it is to pick it up. We will continue to campaign and share our message that it is very much better late than never to vaccinate rabbits against all three killer diseases of rabbits: myxomatosis, Rabbit Viral Haemorrhagic Disease 1 and 2."
PDSA Vet Nurse, Kristiana Shirley, said: "Rabbit Awareness Week provided us with a great opportunity to engage with rabbit owners and raise awareness of the key preventative healthcare our bunnies so vitally need.
"During Rabbit Awareness Week in June, we saw a significant increase in the number of vaccines given when compared to previous months, and an increase in our rabbit MOTs too, which we hope is just the start of a trend which sees more owners protecting their rabbits from preventable, fatal diseases."
For more information on Rabbit Awareness Week, including free access to rabbit CPD, visit www.rabbitawarenessweek.co.uk
The new presentation is honey-flavoured and is available in 30ml or 100ml bottles with a syringe for precise dosing.
It has a two-year shelf life and a broached shelf life of six months.
Dechra companion animal brand manager, Thomas Johnson, said: “The addition of Felimazole Oral to our product range will provide vets with the flexibility to prescribe Felimazole as either a tablet or oral solution to accommodate the preferences of both the cat and its owner.
"This, combined with our extensive endocrinology resources, will ensure that vets have all the necessary tools to support their feline hyperthyroid cases.”
https://www.dechra.co.uk/cushings-connect
https://www.dechra.co.uk/addisons-connect
https://www.dechra.co.uk/search?q=felimazole#/search=Felimazole
https://apps.apple.com/gb/app/dechra-endocrinology-app/id1660737534
Mr Ng faced seven charges:
Mr Ng admitted some aspects of the charges against him, including that he had deleted two patient records and that this was dishonest and misleading.
The Committee then determined the facts of the rest of the charges after hearing evidence from witnesses and Mr Ng himself, as well as expert witnesses.
Having considered all the evidence, it determined which elements of the charges were proved, and which were not.
The Committee then considered whether the admitted and charges found proved amounted to serious professional misconduct.
In doing so it considered that the charges against Mr Ng fell into three broad categories – deficiencies in clinical care, deficiencies in record keeping, and dishonesty.
In respect of all three, it found the admitted and charges found proved amounted to serious professional misconduct.
In terms of aggravating factors, the Committee found that Mr Ng’s conduct had directly caused harm to animals and also created risk of further harm, and noted that there were three instances of dishonesty.
Paul Morris, chairing the Disciplinary Committee and speaking on its behalf, said: “The Committee noted that there were three instances of dishonest behaviour in relation to clinical records.
"The amendment of the clinical record in the labradoodle’s case was particularly serious.
"This alteration was made at a time when the respondent knew that the owner was dissatisfied with the treatment the dog had received and was complaining about the lack of therapeutic intervention.
"The alteration presented a false account of the owner’s attitude towards immediate therapeutic intervention.
"Conduct of this kind was liable to damage trust in the profession.”
In mitigation, the Committee took into account the sense of pressure Mr Ng felt following a financial dispute with his relative in respect of the veterinary practice, his long career as a veterinary surgeon and the high regard with which he was held by those who provided testimonials on his behalf.
The Committee acknowledged Mr Ng’s assertions that he now understood his failings and his expressions of remorse for the harm he had caused and that these indicated the beginnings of insight.
However, in respect of the clinical deficiencies, the Committee found that various aspects of Mr Ng’s approach to treating conditions such as diabetes and cherry eye were inadequate and out-of-date, and that there was little in his continuing professional development (CPD) record or his statements to suggest he had attempted to improve these deficiencies.
Ultimately, the Committee found that Mr Ng’s conduct was so serious that removal from the Register was the most appropriate sanction.
Paul Morris added: “The Committee has concluded that the respondent’s behaviour was fundamentally incompatible with being a veterinary surgeon.
"In view of the nature and gravity of the Committee’s findings in this case, removal from the Register is necessary to ensure the protection of animals and the maintenance of public confidence in the profession and the regulatory process.”
www.rcvs.org.uk/disciplinary
Virbac, maker of Pronefra for the management of CKD in cats and dogs, has launched a free app to help interpret patients' urine test results in line with the latest International Renal Interest Society (IRIS) Guidelines.
The app, which is also called Pronefra, is available for download on both the Play store and Apple store.
Simon Boulton MRCVS, Marketing Manager for Companion Animals, said: "Reference ranges supplied by machines and labs are not always appropriate for the renal patient so we wanted to help practices to interpret kidney-specific results quickly and easily in line with the latest recommendations. The Pronefra app was the result. We have received very positive feedback on the app so far and hope it will help practices improve the quality and length of life of their renal patients."
Virbac is also providing further Pronefra practice support materials, include a pet health recording book for clients to aid in compliance and other educational tools for vets, nurses and clients.
Ceva Animal Health has launched Feliway Friends, a new pheromone to help reduce tensions and conflicts in households with more than one cat.
The company highlights a 2014 survey which found that 44% of cat owning households have more than one cat, with nearly a third of those questioned stating that they had experienced fighting and aggression between pets in the household1.
Feliway Friends is a synthetic copy of the cat appeasing pheromone (CAP) naturally produced by nursing queens to support their kittens after birth. The company says this pheromone helps cats feel safe and secure, and maintains a harmonious bond between them.
Ceva says Feliway Friends is clinically proven to significantly decrease the intensity and frequency of signs of tension in households with more than one cat. According to another study, 84% of cat owners believed there was a significant improvement in how their cats got on after using the product2.
Feliway Friends and Feliway Classic can be used at the same time if the owner is experiencing conflicts alongside other stress-related behaviour problems such as urine marking, scratch marking and general anxiety.
Available as a 30-day diffuser and refill, Feliway Friends lasts for up to 30 days and covers an area of up to 70m2.
Claire Russell, Feliway product manager at Ceva Animal Health, said: "Inter-cat aggression is a major problem in multi-cat households, with many cats experiencing stress in the home due to sharing resources. Feliway Friends is a great support to encourage harmony in multi-cat homes. By introducing the cat appeasing pheromone and educating owners on resource management and how to create a cat friendly home, we can significantly improve feline relationships in our UK multi-cat homes.’’
Ceva Animal Health has launched a range of marketing materials to support the launch of the new product, including an eight-page pet owner leaflet and poster. Practices can also request an online toolkit which includes: images, website content, social media assets and articles to help educate clients facing aggression between household cats.
For information on FELIWAY visit www.feliway.com/uk.
References
Undertaken in practice, industry and academia, submissions are open each year offering the chance to present a Clinical Abstract, presented as a poster or an oral presentation.
Christine Pye won the Medicine Award for her longitudinal study of age, sex and health-related changes in physical biomarkers in pet cats
Alberto Sesana won the Surgery Award for his abstract: "Outcome of lip-to-lid subdermal plexus flaps to reconstruct defects of the lower eyelid in dogs and cats: 46 cases (2005-2022)."
Deborah Komianos won the Practitioner Award for "Reducing use of critically important antibiotics: A clinician-led improvement project across 21 UK small animal veterinary practices."
Rosemary Perkins won the Poster Award for: "Swimming emissions from dogs treated with spot-on fipronil and imidacloprid: assessing the environmental risk."
Lastly but not leastly, Claudia Franzini won the Student Award for: "Does the surgical method for management of Cranial Cruciate Ligament Rupture in dogs affect clinical outcome?"
Submissions for the 2026 Clinical Abstracts will open on 8th September 2025.
https://www.bsavacongress.com
Photo: L-R, Alberto Sesana, Deborah Komianos, Christine Pye, Rosemary Perkins, Claudia Franzini
Focusing on the approach, diagnosis and treatment of regurgitation in dogs and cats, the webinar looks at how to differentiate regurgitation from vomiting and the way some diseases can cause inflammation, obstruction or dysmotility of the oesophagus, which can often result in regurgitation.
Aarti Kathrani graduated from the Royal Veterinary College (RVC) and is now a Senior Lecturer in Small Animal Internal Medicine, where she is involved with the clinical internal medicine service. She also helps provide nutritional input to clinical cases seen at the Queen Mother Hospital for Animals, where her research centres on canine and feline gastroenterology and nutrition.
Aarti said: “The webinar is designed to help general practitioners differentiate between regurgitation and vomiting, as well as provide a comprehensive review of the different causes of regurgitation and the diagnostic approach to this. Treatment is also discussed for this condition. We hope the webinar provides a useful guide to help diagnose and manage these cases in general practice.”
The regurgitation lecture is freely available and can be accessed via the Webinar Library here: https://www.bsavalibrary.com/content/webinar-library.
The lecture complements the BSAVA Manual of Canine and Feline Gastroenterology, which was published in 2019 to give readers a greater insight into the GI conditions they are treating. The Manual is divided into four main sections, focusing on; Diagnostic procedures and techniques; Diagnostic approaches to problems; Patient Management; Diseases of specific systems/organs.
The Manual costs £60.00 for BSAVA members; £90.00 for non-members and can be purchased from the BSAVA website here: https://www.bsava.com/Shop/Veterinary-books#!prod/f1a8220f-3ff7-e911-80e7-005056be4acd/curr/GBP
As Ceva points out, the change gives veterinary surgeons an opportunity to get more involved in parasite control plans and help farmers develop a sustainable parasite control strategy on their farm.
Eprecis injectable contains eprinomectin, the only molecule with zero-milk withdrawal currently available for cattle on the U.K. market.
Ceva highlights that because Eprecis is an injection, there is no risk of product transfer between in-contact animals caused by licking1,2,3 a natural behaviour of cattle, potentially resulting in sub-therapeutic levels of product being absorbed. There is also no risk of reduction in efficacy if dirt or manure is present on the back of the animal4.
The company says injectable formulation results in less active ingredient per animal treated compared to eprinomectin pour-ons; for example using Eprecis injection, a 500kg animal receives 100mg eprinomectin, while a pour-on delivers 250mg per application.
To support the new POM-V classification, Ceva has launched a vet support pack to help veterinary professionals when talking to their farming clients about Eprecis, worming strategies and their parasite control plans. The pack contains a farmer targeted brochure, farmer Q&A and a practical guide with suggestions of when Eprecis can be used. It also includes an infograph for social media posts, a technical booklet and a vet Q&A to help answer the most common questions they may be asked. A series of social media posts are available for vet practices encouraging their clients to discuss worming with their vet.
Kythé Mackenzie BVSc MRCVS, ruminant veterinary adviser at Ceva Animal Health, said: “Ruminants can be parasitised by a range of nematodes, trematodes and external parasites, all of which can have an impact on health and production. A recent publication considered that helminth infections (GIN, lungworm and liver fluke) cost the UK dairy industry close to £145M per year5. Interestingly, the majority of these costs were attributed to lost production (£131M) rather than treatment costs (£14M).
“There is now documented resistance to eprinomectin in small ruminants6 (Haemonchus contortus in goats) and whilst not yet documented in cattle, action needs to be taken to try and delay/minimise this emergence. This requires the use of more sustainable parasite control plans to assist in managing refugia and allowing animals adequate exposure to the parasites to develop natural immunity. Parasite control plans should maximise health, welfare and production whilst minimising the unnecessary use of anthelmintics.”
In the short-term, orders of Eprecis injectable from veterinary wholesalers will be fulfilled by the current POM-VPS product that is in the supply chain before switching to the new packaging later in the season.
For further information contact your local Ceva Animal Health territory manager or email cevauk@ceva.com.
Elanco has announced that it has finalised its acquisition of Novartis Animal Health.
The acquisition, announced in April last year, follows Elanco's purchase of Lohmann Animal Health earlier in 2014. It swells Elanco's portfolio to nearly 300 brands encompassing therapeutics, vaccines, parasiticides, antimicrobials, surgical, enzymes, food safety and more.
Gaynor Hillier, Elanco's General Manager UK and Ireland said: "Elanco's acquisition of Novartis Animal Health brings together two strong companies with a passion for serving the customer. We will continue to offer the products our customers trust, while significantly investing in the development of new solutions to meet our customers' greatest unmet needs."
The company says it will now increase investment in research and development significantly, with a combined portfolio of more than 100 product development projects focused on:
Gaynor added: "We'll continually seek innovative ways we can support our customers' business. With increased technical services, that combine our analytic and benchmarking tools with on-the-ground support, we'll be able to spend more time with individual customers seeking innovative solutions that can make a difference in their business."
Elanco says that the complete integration of the businesses will take some time, but it is trying to make the transition seamless. For the foreseeable future, business will continue in much the same way, including product ordering and customer support. Availability and access to products will continue uninterrupted.
For more information about the acquisition, visit www.elanco.com.
There will now be significant changes to the RCVS Council, as follows:
A gradual reduction in the number of elected members of RCVS Council from the current 24 to 13 by the year 2021.
A change of composition to include six lay members and two veterinary nurse members. Furthermore, the number of Council members appointed by each university whose veterinary degree is recognised by the RCVS will be reduced from two to one and Privy Council will no longer be required to appoint members. From 1 July 2020 university membership will undergo further changes as, from then on, veterinary schools will collectively appoint three members in total to serve on Council.
Members of Council will no longer be able to serve more than three consecutive four-year terms of office and, after serving three consecutive terms, they will not be eligible to re-stand as a candidate for two years.
Members of Council may be removed from office if they fail to satisfy any conditions about fitness to be a member, as determined by their peers on Council. If removed from office they will not be eligible to re-stand as a candidate for two years.
Introducing the LRO before the House of Lords last Tuesday, Lord Gardiner of Kimble said: "The proposed changes… reduce the size of Council and revise the balance of membership between vets and non-vets, including veterinary nurses and lay persons. They will bring the RCVS in-line with many other modern-day regulatory bodies and allow for greater efficiency, transparency and accountability to both members and the general public. For all the reasons I have outlined today, I commend the use of Legislative Reform Order to make changes that will benefit the veterinary profession."
The full text of the Legislative Reform Order can be found on www.legislation.gov.uk and the full transcript of the debate in the House of Lords can be found in Hansard Online (https://hansard.parliament.uk).
Professor Stephen May, RCVS President, said: "We have been looking at reform of Council as an issue of some urgency since 2013, in recognition of the fact that, with the formula-driven growth of Council, it was becoming unwieldy, which has an impact on the cost of each meeting and the frequency with which it could reasonably meet.
"This reform has been long in gestation and so we are glad that this has now been approved and that we can look forward to a more modern, agile and efficient governance structure, aimed as always at benefitting the professions, animal owners and animal health and welfare."
One immediate impact of the LRO relates to the results of this year’s RCVS Council election as the Ministerial sign-off now confirms that only the first three candidates (in order of number of votes) will take up their four-year terms at RCVS Day on Friday 13 July 2018. These are Susan Paterson, Mandisa Greene and Neil Smith, all of whom are current members who were re-elected.
The RCVS Veterinary Nurses Council agreed reforms to its own governance last year, including shortening the term of office from four years to three years; introducing a consecutive three-term limit for elected members; and, reducing the size and changing the composition of VN Council to six elected veterinary nurses, two appointed veterinary nurse members, two appointed veterinary surgeon members from RCVS Council, and four appointed lay members.
For every 'Proud to support Dogs for Good' profile picture changed and tagged with @PetMagicMoments and #dogsaregood, Elanco will donate £1 to the charity that trains dogs to give life-changing assistance to people with disabilities.
The company is hoping to raise up to £5,000 for its long-term charity partner through the Pet Magic Moments - https://www.facebook.com/PetMagicMoments/ - Facebook picture initiative, with an overall aim of raising in excess of £15,000 in total for Dogs for Good to support the training of three assistance dogs.
Elanco says it will raise additional money through fundraising activities and employees will also be encouraged to carry out voluntary work to support Dogs for Good in the three days a year they are given to volunteer for worthwhile charities.
Matthew Rowe, marketing manager at Elanco Animal Health, said: "Our Dogs for Good Facebook picture initiative will help highlight the profile of this wonderful and inspiring charity, while raising funds to support the training of an assistance dog."
Dogs for Good (the new name for Dogs for the Disabled) is an innovative charity, exploring ways dogs can help people overcome specific challenges and enrich and improve lives and communities.
Its assistance dogs support adults and children with a range of disabilities and also children with autism. It trains activity and therapy dogs to work with specialist handlers in communities and schools and its Family Dog team also gives specialist advice and support to help people get the most out of their relationship with their pet dog.
For further information about the charity, visit www.dogsforgood.org or call on 01295 252600.
The clinic will be headed up by Dr Ursula Dietrich, an RCVS Specialist in Veterinary Ophthalmology, who will be stepping down as senior lecturer in veterinary ophthalmology at The Royal Veterinary College to take up her new post.
Ursula has held a number of prestigious positions including Chair of the Scientific Committee of European College of Veterinary Ophthalmologists from 2007-2012, member of the Examination Committee of the American College of Veterinary Ophthalmologists from 2002-2006 and Associate Editor (Ophthalmology) of the Journal of Small Animal Practice since 2012-18. She also holds Diplomas from the American and European Colleges of Veterinary Opthalmologists.
Ursula said: “I am thrilled to take on this new role, heading up The London Cat Clinic’s new opthalmology centre. The clinic is doing wonderful things in feline veterinary care as the largest specialist practice devoted solely to cats in the UK. The ophthalmology service is the next exciting development in achieving our goal of being a centre of excellence in feline veterinary medicine."
London Cat Clinic Founder, Dr Jeremy Campbell, said: “We are delighted to welcome Dr Dietrich to the team, as she brings with her a wealth of experience in the field of feline ophthalmology. She will be a wonderful asset to The London Cat Clinic, as we embark on an exciting new chapter.”
For more information about referring a case to The London Cat Clinic, visit: https://www.thelondoncatclinic.co.uk/